The abstract showing the results of a Phase 2 clinical study of BEMA Buprenorphine in the treatment of pain has been selected for oral presentation at Pain Week 2010, a national conference educating frontline clinicians who are faced with treating patients with pain. The presentation will take place on Friday, September 10, as part of the 7:00 - 9:00 AM podium presentation session.
Link:http://markets.financialcontent.com/ir/?Module=MediaViewer&GUID=14494495&Ticker=BDSI
Source:BioDelivery Sciences

Orphan drug designation from the U.S. Food and Drug Administration (FDA) for BMN-701, a novel fusion of insulin-like growth factor 2 and alpha glucosidase (IGF2-GAA) in development for the treatment of Pompe disease has been received.
Link:http://phx.corporate-ir.net/phoenix.zhtml?c=106657&p=RssLanding&cat=news&id=1464587
Source:BioMarin

Preliminary top-line results from an 8-week Phase II clinical trial of the novel, investigational antipsychotic agent cariprazine for the treatment of bipolar depression were announced.
Cariprazine, discovered by researchers at Gedeon Richter, is an orally active, potent D3/D2 partial agonist that preferentially binds to D3 receptors.
Link:http://www.frx.com/news/PressRelease.aspx?ID=1464447
Source:Forest

The publication of new data supporting the safety and efficacy of Caldolor (ibuprofen) Injection in pre and post-operative orthopedic surgery patients was announced. The study, which was published in the August edition of the peer-reviewed journal Pain Medicine, concludes that IV ibuprofen significantly decreased pain and morphine use when compared with placebo.
Link:http://investor.shareholder.com/cpix/releasedetail.cfm?ReleaseID=503366
Source:Cumberland

Patients taking Eisai’s E5555 together with drugs currently used in standard treatment were no more likely to suffer the side effect than people taking placebos, the studies released today at the European Society of Cardiology Congress in Stockholm showed.
The researchers tested E5555 in Japanese patients being treated for acute coronary syndrome or coronary artery disease, conditions that occur when plaque builds up in arteries and blocks blood flow. These conditions can lead to chest pain known as angina and to heart attacks.
Link:http://noir.bloomberg.com/apps/news?pid=newsarchive&sid=aC_oHLu6AcFs
Source:Bloomberg

It may soon be possible to identify patients who will develop tuberculosis, as scientists have identified changes in the blood specific to the disease, blood transcriptional signatures. These findings are from an international study published in the August 19 issue of Nature and conducted by doctors and researchers using blood profiling techniques to understand infections.
Link:http://www.eurekalert.org/pub_releases/2010-08/nch-ngm082710.php
Source:EurekAlert

Roche's pipeline of cancer drugs faced another setback on Friday after the U.S. Food and Drug Administration rejected the Swiss drugmaker's request to fast-track a licence application for a new treatment.
The drug trastuzumab-DM1 (T-DM1) comprises ImmunoGen's DM1 cancer-cell-killing agent linked to the HER2-targeting antibody trastuzumab, or Herceptin.
Friday's delay pertains to the drug's approval as a treatment for third-line metastatic breast cancer.
Link:http://www.reuters.com/article/idUSLDE67Q03620100827
Source:Reuters

Europe's drug regulator is reviewing the safety of GlaxoSmithKline's Pandemrix flu vaccine, which has been given to more than 30 million people in Europe, to investigate possible links to a sleep disorder.
Link:http://www.reuters.com/article/idUSTRE67Q2VV20100827
Source:Reuters

Mothers who did not breastfeed their children have significantly higher rates of type 2 diabetes later in life than moms who breastfed.
It is reported in the September issue of the American Journal of Medicine.
Link:http://www.eurekalert.org/pub_releases/2010-08/uops-mwd082510.php
Source:EurekAlert

The number of children admitted to English hospitals with bacterial pneumonia decreased by a fifth in the two years following the introduction of a vaccine to combat the disease, according to a new study published today in the journal Thorax.
Link:http://www.eurekalert.org/pub_releases/2010-08/icl-vhc082610.php
Source:EurekAlert